Delcath Systems Inc Call with Dr. Jonathan Zager, Principal Investigator for Delcath's Ph3 FOCUS Study Transcript
Good morning, ladies and gentlemen. Welcome to the Encode Ideas, L.P. key opinion leader call with Dr. Jonathan Zager, Principal Investigator for Delcath's Phase 3 FOCUS study. As a reminder, this conference call is being recorded. I would now like to turn the meeting over to Hogan Mullally, Partner, Encode Ideas.
Thank you, and welcome, everyone, to the call. We really appreciate you participating. My name is Hogan Mullally. I am a Partner at Encode Ideas. I'm pleased to be joined on this call by Dr. Jonathan Zager, Chief Academic Officer and a surgical oncologist and senior member of the Department of Cutaneous Oncology and Sarcoma at Moffitt Cancer Center.
Dr. Zager is also the principal investigator in the pivotal Phase 3 FOCUS study investigating melphalan hepatic delivery system via percutaneous hepatic perfusion or as we'll refer to it throughout the call PHP in the treatment of metastatic ocular melanoma.
Before we begin our discussion on metastatic ocular melanoma and PHP, I'd like to run
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
